Antares Pharma, Inc. (AIS.A)

AIS.A on American Stock Exchange

1.14USD
4:01pm EST
Price Change (% chg)

$0.04 (+3.64%)
Prev Close
$1.10
Open
$1.10
Day's High
$1.14
Day's Low
$1.10
Volume
85,800
Avg. Vol
186,968
52-wk High
$1.31
52-wk Low
$0.30

AIS.A

Chart for AIS.A

About

Antares Pharma, Inc. (Antares) is a product development and pipeline company with drug delivery platforms, including Advanced Transdermal Delivery (ATD) gels, disposable pressure assisted auto injection systems (Vibex), reusable needle-free injection systems (VISION), disposable pen injection systems and oral disintegrating... (more)

Overall

Beta: 1.00
Market Cap (Mil.): $89.06
Shares Outstanding (Mil.): 81.71
Annual Dividend: 0.00
Yield (%): NA

Financials

  AIS.A Industry Sector
P/E (TTM): -- 4.06 4.69
EPS (TTM): 23.33 -- --
ROI: -74.02 2.78 2.76
ROE: -102.95 4.39 3.51
view overview for:

Latest News about AIS.A

UPDATE 2-Teva, Antares get FDA nod for needle-free device

* Needle-free device to administer human growth hormone

29 Jun 2009

STOCKS NEWS US-Teva, Antares get FDA nod for needle-free device

For U.S. stock market report double-click [.N] 0916 ET 29June2009-Teva, Antares get FDA nod for needle-free device ------------------------------------------------------------------------------

29 Jun 2009

BRIEF-Antares Pharma receives milestone payment

Dec 19 (Reuters) - ANTARES PHARMA INC : * Antares Pharma receives milestone payment * Says received added milestone payment of $875,000 from BioSante Pharmaceuticals

19 Dec 2007

Antares Pharma Q3 results

ANTARES PHARMA INC : * Third quarter loss per share $0.04 * Third quarter revenue $1.2 million * Reuters Estimates third quarter loss per share view $0.04, revenue view $1.69 million

13 Nov 2007

TABLE-Antares Pharma Q2 loss narrows slightly

ANTARES PHARMA INC. (In $) Latest Yr-ago qtr Loss/shr (diluted) 0.04 0.05 Net loss (million) 2.3 2.5 Total revenue (thousands) 1,806 859 Reuters Estimates: Loss/shr $0.05, revenue $1.0 million (Reporting by Sreerupa Mitra in Bangalore)

13 Aug 2007

Antares to raise $15 mln from private placement

June 29 (Reuters) - Antares Pharma <AIS.A) said it will raise about $15 million from a private placement of newly-issued common shares and concurrent issuance of warrants.

29 Jun 2007
» More AIS.A News

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $64.41 -0.50
Elan Corporation, plc (ELN.I) €4.20 -0.30
SkyePharma PLC (SKP.L) £88.00 +1.50
Alkermes, Inc. (ALKS.OQ) $9.41 -0.15
Alkermes, Inc. (ALKSP.OQ) -- --
Watson Pharmaceuticals, Inc. (WPI.N) $39.61 -0.21
Solvay S.A. (SOLB.BR) €75.55 -0.26
NexMed, Inc. (NEXM.OQ) $0.28 -0.01
Auxilium Pharmaceuticals, Inc. (AUXL.OQ) $29.98 +0.35
Novavax, Inc. (NVAX.OQ) $2.66 +0.08

  Earnings  vs    Estimates

view overview for: